MiniMed Group Statistics
Total Valuation
MiniMed Group has a market cap or net worth of $5.06 billion. The enterprise value is $4.92 billion.
| Market Cap | 5.06B |
| Enterprise Value | 4.92B |
Important Dates
The next estimated earnings date is Tuesday, November 10, 2026, after market close.
| Earnings Date | Nov 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MiniMed Group has 281.35 million shares outstanding. The number of shares has increased by 4.29% in one year.
| Current Share Class | 281.35M |
| Shares Outstanding | 281.35M |
| Shares Change (YoY) | +4.29% |
| Shares Change (QoQ) | +4.81% |
| Owned by Insiders (%) | 0.02% |
| Owned by Institutions (%) | 13.43% |
| Float | 28.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 27.96 |
| PS Ratio | 1.57 |
| Forward PS | 1.46 |
| PB Ratio | 1.31 |
| P/TBV Ratio | 4.01 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.53 |
| EV / EBITDA | 17.22 |
| EV / EBIT | 38.49 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.81, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.81 |
| Quick Ratio | 1.26 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.20 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -8.66% and return on invested capital (ROIC) is 2.26%.
| Return on Equity (ROE) | -8.66% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 2.26% |
| Return on Capital Employed (ROCE) | 3.25% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $402,750 |
| Profits Per Employee | -$39,250 |
| Employee Count | 8,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MiniMed Group has paid $129.00 million in taxes.
| Income Tax | 129.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 20.47 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 38.36 |
| Average Volume (20 Days) | 14,313,912 |
Short Selling Information
The latest short interest is 18.20 million, so 6.47% of the outstanding shares have been sold short.
| Short Interest | 18.20M |
| Short Previous Month | 13.59M |
| Short % of Shares Out | 6.47% |
| Short % of Float | 63.93% |
| Short Ratio (days to cover) | 6.07 |
Income Statement
In the last 12 months, MiniMed Group had revenue of $3.22 billion and -$314.00 million in losses. Loss per share was -$1.19.
| Revenue | 3.22B |
| Gross Profit | 1.83B |
| Operating Income | 128.00M |
| Pretax Income | -172.00M |
| Net Income | -314.00M |
| EBITDA | 286.00M |
| EBIT | 128.00M |
| Loss Per Share | -$1.19 |
Balance Sheet
The company has $207.00 million in cash and $59.00 million in debt, with a net cash position of $148.00 million or $0.53 per share.
| Cash & Cash Equivalents | 207.00M |
| Total Debt | 59.00M |
| Net Cash | 148.00M |
| Net Cash Per Share | $0.53 |
| Equity (Book Value) | 3.62B |
| Book Value Per Share | 12.87 |
| Working Capital | 635.00M |
Cash Flow
In the last 12 months, operating cash flow was -$105.00 million and capital expenditures -$211.00 million, giving a free cash flow of -$316.00 million.
| Operating Cash Flow | -105.00M |
| Capital Expenditures | -211.00M |
| Depreciation & Amortization | 158.00M |
| Net Borrowing | n/a |
| Free Cash Flow | -316.00M |
| FCF Per Share | -$1.12 |
Margins
Gross margin is 56.89%, with operating and profit margins of 3.97% and -9.75%.
| Gross Margin | 56.89% |
| Operating Margin | 3.97% |
| Pretax Margin | -5.34% |
| Profit Margin | -9.75% |
| EBITDA Margin | 8.88% |
| EBIT Margin | 3.97% |
| FCF Margin | n/a |
Dividends & Yields
MiniMed Group does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -4.29% |
| Shareholder Yield | -4.29% |
| Earnings Yield | -6.19% |
| FCF Yield | -6.23% |
Analyst Forecast
The average price target for MiniMed Group is $25.00, which is 38.89% higher than the current price. The consensus rating is "Buy".
| Price Target | $25.00 |
| Price Target Difference | 38.89% |
| Analyst Consensus | Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (3Y) | 9.75% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MiniMed Group has an Altman Z-Score of 3.12 and a Piotroski F-Score of 2.
| Altman Z-Score | 3.12 |
| Piotroski F-Score | 2 |